Vernon b

VERNON B. WILLIAMS, M.D.
6801 Park Terrace. Los Angeles, CA 90045
EDUCATION
University of Michigan, Ann Arbor, MI
Inteflex Accelerated Pre-Medical/Medical Program

POST-GRADUATE
TRAINING

1996 - 1997
Johns Hopkins Hospital, Baltimore, MD
Department of Anesthesiology and Critical Care
1993 - 1996
University of Maryland Medical Center, Baltimore, MD

1992 - 1993
Intern
Henry Ford Hospital, Detroit, MI


EMPLOYMENT
HISTORY

2007- Present
Sports Concussion Institute, Los Angeles, CA

1997 - Present

Director, Sports Neurology and Pain Management Kerlan-Jobe Orthopaedic Clinic, Los Angeles, CA

2005 – 2006

Director of Sports Neurology and Pain Management Sports Concussion Institute, Marina Del Rey, CA

1999 – 2005

Medical Director-HealthSouth Physical Therapy Integrated Medical Plaza, Los Angeles, CA

1994 – 1998

Innovative Medical Research, Incorporated, Towson, MD

1995 - 1996
Director of Medical Student Core Neurology Curriculum University of Maryland Medical Center, Baltimore, MD


1994 - 1996
Ethical Advisory Committee Member University of Maryland Medical Center, Baltimore, MD
Student Fellow of the American Heart Association Henry Ford Hospital/Wayne County Medical Examiner’s Office
Detroit, MI
University of Michigan Medical Center, Ann Arbor, MI
Department of Physical Medicine and Rehabilitation

1984 - 1986

Henry Ford Hospital, Detroit, MI

PUBLICATIONS
1. . Cocaine Associated Intracranial Hemorrhage: Absence of Vasculitis in Fourteen Cases. 1. . Williams V, Pappagallo M. Central Pain. In: Raja S (Ed.) Essentials of Pain Medicine. 1. . Williams V, Pappagallo M. Entrapment neuropathies. In: Raja S (Ed.) Essentials of Pain Williams V, Staats P. Intrathecal Baclofen for the Management of Uncontrolled Spasticity. PAIN DIGEST, 1998;8:158-165
CLINICAL
RESEARCH

As Primary Investigator:
Phase II, Double Blind, Placebo Controlled, Parallel, Four Week Evaluation of Efficacy and
Safety of Multiple Doses of CJ-13,974 in Subjects With Moderate to Severe Chronic Back Pain. Kerlan-Jobe Orthopedic Clinic. Los Angeles, CA; 1998 A Multicenter Double Blind, Randomized, Placebo Controlled, Parallel Group Clinical study of the Safety, and Efficacy of Botox (Botulinum Toxin Type-A) Purified Neurotoxin Complex Injections Into Local Areas of Muscle Spasm in Subjects With Chronic Low Back Pain. Kerlan-Jobe Orthopedic Clinic. Los Angeles, CA; 1999 A Multicenter, Double-Blind, Placebo Controlled, Parallel Group, Study of Two Dose Levels of Oral Eletriptan and Two Dose Levels of Oral Sumatriptan For The Acute Treatment of Migraine. Innovative Medical Research. Baltimore, MD; 1996. Two-Period Crossover Comparison of Rizatriptan (5mg p.o. and 10mg p.o.) To Sumatriptan (25mg p.o. and 50mg p.o.) Innovative Medical Research. Baltimore, MD; 1996 A Randomized, Double-Blind, Placebo-Controlled, Twelve Month Safety and Efficacy Trial of 120, 240, and 360mg TID of Idebenone (CV-2619) In Patients With Probable Alzheimer's Disease. Innovative Medical Research. Baltimore, MD; 1996 Protocol for a multicentre, long-term study to maximize migraine relief with 311C90 (MAXIMM). Innovative Medical Research. Baltimore, MD; 1996
As Sub-Investigator:
A randomized, parallel, double-blind, double-dummy, placebo-controlled study to determine the
onset of action of PHZ 136 and Motrin IB in patients with acute muscle-contraction (tension) headache. Innovative Medical Research. Baltimore, MD; 1996 The efficacy and safety of alniditan (1.4 0r 1.8mg SC) vs. sumatriptan (6mg SC) in the acute treatment of migraine: a randomized, double-blind, placebo controlled single-dose trial. Innovative Medical Research. Baltimore, MD; 1996 A randomized, double-blind, placebo-controlled, parallel group, multicenter, single-dose, dose- range-finding study to assess the efficacy and tolerability of VML 251 in the acute treatment of migraine. Innovative Medical Research. Baltimore, MD; 1996 An open, multicenter study to evaluate the safety of a recombinant DNA-expressed protein vaccine for Lyme disease in subjects previously enrolled in Lyme 008 and 005 studies. Innovative Medical Research. Baltimore, MD; 1996 A clinic initiated, double-blind, placebo-controlled, multicenter study to assess the safety and efficacy of topical n-docosanol 10% cream (Lidakol) in patients with early stage episodes of acute, recurrent herpes labialis. Innovative Medical Research. Baltimore, MD; 1996 An active comparator-controlled, parallel-group, one year, double-blind study, conducted under in-house blinding conditions, to assess the safety and efficacy of MK-0966 vs. diclofenac sodium in patients with osteoarthritis of the knee or hip. Innovative Medical Research. Baltimore, MD; 1996 A randomized, parallel, double-blind, placebo-controlled study to determine the onset of action of Excedrin Extra Strength and Advil in episodic tension-type headache pain. Innovative Medical Research. Baltimore, MD; 1995 A single-center, double blind, randomized, parallel-group, single dose, placebo-controlled study to evaluate safety and effectiveness of Excedrin Extra Strength in alleviating the headache pain of an acute migraine attack. Innovative Medical Research. Baltimore, MD; 1995 Evaluation of the protective efficacy, safety, and immunogenicity of a recombinant DNA- expressed protein vaccine for Lyme disease in healthy subjects. Innovative Medical Research. Baltimore, MD; 1995 A clinic initiated longitudinal study entitled Assessing Migraine Severity II: Identifying Migraneurs Most in Need of Care. Innovative medical Research. Baltimore, MD; 1994
INVITED LECTURE/
CONSULTANT
ACTIVITIES
Daniel Freeman Marina Orthopedic Grand Rounds HealthSouth Worker’s Compensation Symposium Kerlan-Jobe Orthopaedic Clinic Worker's Compensation Update Centinela Medical Center Physician’s Retreat Grand Rounds Cedars-Sinai Department of Neurosurgery SEIU UHW West & Joint Employer Education Fund Community Lecture-Pain Management, Marina Del Rey Community Lecture-Pain Management, Irvine Community Lecture-Pain Management, Manhattan Beach Community Lecture-Non-Surgical Spine Treatment, Torrance American Academy of Neurology National Conference American Academy of Neurology National Conference Sports Concussion Institute Annual Summit on Concussion Plenary Session Speaker and Session Lecturer 2007 Sports Concussion Institute Annual Summit on Concussion Plenary Session Speaker and Session Lecturer 2008 Sports Concussion Institute Annual Summit on Concussion Plenary Session Speaker and Session Lecturer 2009 Co-Chair Sports Concussion Institute Annual Summit 2009 The “Contender” Reality Boxing television series 2007-2008

PROFESSIONAL
MEMBERSHIPS/
BOARD ACTIVITES

Kerlan-Jobe Orthopaedic Foundation Board of Directors Team HEAL Board of Directors Velocity Sports Performance Advisory Board Elite Sports Performance Advisory Board American Medical Association
CERTIFICATION
and LICENSURE

American Board of Psychiatry and Neurology
Medical Board of California : License # G84209
DEA Certification for Opioid Withdrawal w/Buprenorphine

Source: http://www.kerlan-jobe.org/files/Williams_CV.pdf

olibodi.com

MINOXIDIL BAILLEUL 2 %, solution pour application cutanée Veuillez lire attentivement cette notice avant d'utiliser ce médicament. Elle contient des informations importantes pour votre traitement. Ce médicament est une spécialité d'AUTOMEDICATION qui peut être utilisée sans consultation ni prescription d'un médecin. La persistance des symptômes, l'aggravatio

cardiologiaclinica.cl

Diabetes, Síndrome Metabólico y Enfermedad CardiovascularHernán Prat M. Unidad de Factores de Riesgo, Depto. Cardiovascular, Hospital Clínico, Universidad de ChileEntre los factores de riesgo cardiovascular (FRC) más bió la conjunción de hipertensión, hiperglicemia y la gota como conocidos están la hipertensión arterial, el tabaquismo, la un síndrome.(4) Posteriormente, varias otra

Copyright © 2013-2018 Pharmacy Abstracts